Table 2.
Characteristics | High risk (N = 175) | Low risk (N = 175) | Total (N = 350) | p value | |
---|---|---|---|---|---|
Age | <65 | 81 | 69 | 150 | 0.2348 |
≥65 | 94 | 106 | 200 | ||
Stage | Stage I | 21 | 28 | 49 | 0.619 |
Stage II | 55 | 56 | 111 | ||
Stage III | 79 | 76 | 155 | ||
Stage IV | 20 | 15 | 35 | ||
T | T1 | 3 | 13 | 16 | 0.0757 |
T2 | 39 | 35 | 74 | ||
T3 | 78 | 83 | 161 | ||
T4 | 52 | 43 | 95 | ||
TX | 3 | 1 | 4 | ||
M | M0 | 155 | 157 | 312 | 0.9404 |
M1 | 12 | 11 | 23 | ||
MX | 8 | 7 | 15 | ||
N | N0 | 49 | 55 | 104 | 0.8117 |
N1 | 45 | 48 | 93 | ||
N2 | 36 | 36 | 72 | ||
N3 | 40 | 31 | 71 | ||
NX | 5 | 5 | 10 | ||
Gender | Female | 60 | 64 | 124 | 0.7374 |
Male | 115 | 111 | 226 | ||
Grade | G1 | 4 | 5 | 9 | 0.9717 |
G2 | 62 | 63 | 125 | ||
G3 | 104 | 103 | 207 | ||
GX | 5 | 4 | 9 |